Shah Rajeev M. 4
4 · Satsuma Pharmaceuticals, Inc. · Filed Dec 7, 2020
Insider Transaction Report
Form 4
Shah Rajeev M.
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2020-12-03+20,000→ 20,000 totalExercise: $4.60Exp: 2030-12-03→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund") and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option, which will offset advisory fees owed by the Fund and the Account to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
- [F2]The option shall vest in full and become exercisable on the day immediately preceding the 2022 Annual Meeting.